Clareon Panoptix Pro IOL achieves 94% light utilization, enhancing light distribution and optical image contrast for improved patient outcomes. The IOL offers +2.17 diopter intermediate and +3.25 ...

Call 214-220-3937 to schedule a consultation or visit keywhitman.com to find out more.

One of East Texas’ most popular amateur tournament circuits — Outlaw Outdoors — recently announced that the organization is joining the growing list of bass tournament trails around the country ...

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of Clareon® PanOptix® Pro intraocular lens (IOL) for cataract patients ...

PanOptix Pro provides an unprecedented 94% light utilization, compared to a theoretical maximum utilization of 96% for diffractive optics 1-4,*,**,† Clareon PanOptix Pro provides more uninterrupted ...

Marine electronics manufacturer Garmin has expanded its range of GPSMAP plotters with the launch of the GPSMAP 15×3 chartplotter. The chartplotter is Garmin’s first to offer an ultrawide 15-inch ...

Alcon Inc. ALC recently introduced the Clareon PanOptix Pro intraocular lens (IOL) for cataract patients in the United States. PanOptix Pro leverages proprietary ENLIGHTEN NXT Optical technology to ...

Please provide your email address to receive an email when new articles are posted on . Alcon introduced the Clareon PanOptix Pro trifocal IOL, which will be commercially available in the U.S. in May, ...

GENEVA--(BUSINESS WIRE)-- Alcon (ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today the introduction of Clareon ® PanOptix ® Pro intraocular lens (IOL) ...

Fish finder technology has leaped forward in the past few years, from bottom flashers and scrolls of paper to modern digital displays. The most advanced fish finders push the limits of sonar and ...

The following is a summary of “Visual Outcomes and Patient Satisfaction of Two Continuous Range of Vision Intraocular Lenses,” published in the January 2025 issue of Clinical Ophthalmology by ...